TODOERTI, KATIA
TODOERTI, KATIA
Dipartimento di Scienze Cliniche e di Comunità
Activation of long non-coding RNA NEAT1 leads to survival advantage of multiple myeloma cells by supporting a positive regulatory loop with DNA repair proteins
2023 E. Taiana, C. Bandini, V.K. Favasuli, D. Ronchetti, I. Silvestris, N. Puccio, K. Todoerti, S. Erratico, D. Giannandrea, N. Bolli, N. Amodio, A. Ciarrocchi, R. Chiaramonte, Y. Torrente, R. Piva, A. Neri
DIS3 depletion in multiple myeloma causes extensive perturbation in cell cycle progression and centrosome amplification
2023 V.K. Favasuli, D. Ronchetti, I. Silvestris, N. Puccio, G. Fabbiano, V. Traini, K. Todoerti, S. Erratico, A. Ciarrocchi, V. Fragliasso, D. Giannandrea, F. Tumiatti, R. Chiaramonte, Y. Torrente, P. Finelli, E. Morelli, N.C. Munshi, N. Bolli, A. Neri, E. Taìana
Impact on thrombotic risk of canonical and atypical CALR mutations in essential thrombocythemia. A single-center cohort study
2022 S. Fabris, D. Cattaneo, S. Salerio, C. Bucelli, G. Ciceri, R. Pasquale, K. Todoerti, U. Gianelli, L. Baldini, A. Neri, A. Iurlo
Expression levels of NONO, a nuclear protein primarily involved in paraspeckles function, are associated with several deregulated molecular pathways and poor clinical outcome in multiple myeloma
2022 D. Ronchetti, V.K. Favasuli, I. Silvestris, K. Todoerti, F. Torricelli, N. Bolli, A. Ciarrocchi, E. Taiana, A. Neri
DIS3 mutations in multiple myeloma impact the transcriptional signature and clinical outcome
2021 K. Todoerti, D. Ronchetti, V. Favasuli, F. Maura, F. Morabito, N. Bolli, E. Taiana, A. Neri
MiR-22 modulates lenalidomide activity by counteracting myc addiction in multiple myeloma
2021 D. Caracciolo, C. Riillo, G. Juli, F. Scionti, K. Todoerti, N. Polera, K. Grillone, L. Fiorillo, M. Arbitrio, M.T. Di Martino, A. Neri, P. Tagliaferri, P. Tassone
Functional impact of genomic complexity on the transcriptome of Multiple Myeloma
2021 B. Ziccheddu, M.C. Da Via, M. Lionetti, A. Maeda, S. Morlupi, M. Dugo, K. Todoerti, S. Oliva, M. D'Agostino, P. Corradini, O. Landgren, F. Iorio, L. Pettine, A. Pompa, M. Manzoni, L. Baldini, A. Neri, F. Maura, N. Bolli
Dissecting the biological relevance and clinical impact of lncrna miat in multiple myeloma
2021 K. Todoerti, D. Ronchetti, N. Puccio, I. Silvestris, V. Favasuli, N. Amodio, M. Gentile, F. Morabito, A. Neri, E. Taiana
Oleil hydroxytyrosol (Htol) exerts anti-myeloma activity by antagonizing key survival pathways in malignant plasma cells
2021 K. Todoerti, M.E. Gallo Cantafio, M. Oliverio, G. Juli, C. Rocca, R. Citraro, P. Tassone, A. Procopio, G. De Sarro, A. Neri, G. Viglietto, N. Amodio
Bioinformatics Pipeline to Analyze lncRNA Arrays
2021 K. Todoerti, D. Ronchetti, M. Manzoni, E. Taiana, A. Neri, L. Agnelli
Epigenetic Regulation of Mitochondrial Quality Control Genes in Multiple Myeloma: A Sequenom MassARRAY Pilot Investigation on HMCLs
2021 P. D'Aquila, D. Ronchetti, M.E. Gallo Cantafio, K. Todoerti, E. Taiana, F. Fabiani, A. Montesanto, A. Neri, G. Passarino, G. Viglietto, D. Bellizzi, N. Amodio
Spotlight on Melphalan Flufenamide: An Up-and-Coming Therapy for the Treatment of Myeloma
2021 F. Morabito, G. Tripepi, E.A. Martino, E. Vigna, F. Mendicino, L. Morabito, K. Todoerti, H. Al-Janazreh, G. D'Arrigo, F.A. Canale, G. Cutrona, A. Neri, M. Martino, M. Gentile
Apoptosis reprogramming triggered by splicing inhibitors sensitizes multiple myeloma cells to Venetoclax treatment
2021 D. Soncini, C. Martinuzzi, P. Becherini, E. Gelli, S. Ruberti, K. Todoerti, L. Mastracci, P. Contini, A. Cagnetta, A. Laudisi, F. Guolo, P. Minetto, M. Miglino, S. Aquino, R. Varaldo, D. Reverberi, M. Formica, M. Passalacqua, A. Nencioni, A. Neri, M.K. Samur, N.C. Munshi, M. Fulciniti, R.M. Lemoli, M. Cea
ZNF521 Enhances MLL-AF9-Dependent Hematopoietic Stem Cell Transformation in Acute Myeloid Leukemias by Altering the Gene Expression Landscape
2021 E. Chiarella, A. Aloisio, S. Scicchitano, K. Todoerti, E.G. Cosentino, D. Lico, A. Neri, N. Amodio, H.M. Bond, M. Mesuraca
Transcriptomic analysis in multiple myeloma and primary plasma cell leukemia with t(11;14) reveals different expression patterns with biological implications in venetoclax sensitivity
2021 K. Todoerti, E. Taiana, N. Puccio, V. Favasuli, M. Lionetti, I. Silvestris, M. Gentile, P. Musto, F. Morabito, U. Gianelli, N. Bolli, L. Baldini, A. Neri, D. Ronchetti
Specific targeting of the KRAS mutational landscape in myeloma as a tool to unveil the elicited anti-tumor activity
2021 A. Sacco, C. Federico, K. Todoerti, B. Ziccheddu, V. Palermo, A. Giacomini, C. Ravelli, F. Maccarinelli, G. Bianchi, A. Belotti, R. Ribolla, V. Favasuli, A.S. Revenko, R.A. MacLeod, B.S. Willis, H. Cai, J. Hauser, C. Rooney, S.E. Willis, P.L. Martin, A.D. Staniszewska, H. Ambrose, L. Hanson, C. Cattaneo, A. Tucci, G. Rossi, R. Ronca, A. Neri, S. Mitola, N. Bolli, M. Presta, M. Moschetta, S. Ross, A.M. Roccaro
Cancer Associated Fibroblasts and Senescent Thyroid Cells in the Invasive Front of Thyroid Carcinoma
2020 E. Minna, S. Brich, K. Todoerti, S. Pilotti, P. Collini, E. Bonaldi, P. Romeo, L.D. Cecco, M. Dugo, F. Perrone, A. Busico, A. Vingiani, I. Bersani, A. Anichini, R. Mortarini, A. Neri, G. Pruneri, A. Greco, M.G. Borrello
Amino acid depletion triggered by L-asparaginase sensitizes MM cells to carfilzomib by inducing mitochondria ROS-mediated cell death
2020 D. Soncini, P. Minetto, C. Martinuzzi, P. Becherini, V. Fenu, F. Guolo, K. Todoerti, G. Calice, P. Contini, M. Miglino, G. Rivoli, S. Aquino, A. Dominietto, A. Cagnetta, M. Passalacqua, S. Bruzzone, A. Nencioni, M. Zucchetti, T. Ceruti, A. Neri, R.M. Lemoli, M. Cea
Chronic lymphocytic leukemia cells impair osteoblastogenesis and promote osteoclastogenesis: role of TNFα, IL-6 and IL-11 cytokines
2020 P. Giannoni, C. Marini, G. Cutrona, S. Matis, M.C. Capra, F. Puglisi, P. Luzzi, S. Pigozzi, G. Gaggero, A. Neri, K. Todoerti, F. Morabito, A. Ibatici, M. Miglino, M. Bergamaschi, S. Bruno, G.M. Sambuceti, J.L. Ravetti, M. Ferrarini, F. Fais, D. de Totero
Long non-coding RNA NEAT1 targeting impairs the DNA repair machinery and triggers anti-tumor activity in multiple myeloma
2020 E. Taiana, V. Favasuli, D. Ronchetti, K. Todoerti, F. Pelizzoni, M. Manzoni, M. Barbieri, S. Fabris, I. Silvestris, M.E. Gallo Cantafio, N. Platonova, V. Zuccalà, L. Maltese, D. Soncini, S. Ruberti, M. Cea, R. Chiaramonte, N. Amodio, P. Tassone, L. Agnelli, A. Neri